Arvinas Collaborates with Merck & Co. on Novel Therapeutics

09.04.2015 - Private US biotechnology company Arvinas has announced a multi-year collaboration with Merck & Co. to create novel therapeutics using its PROTAC (proteolysis-targeting chimeras)...